CALA News and Press, Calithera Biosciences Inc. From 07/03/19

"The merit of all things lies in their difficulty." - Alexandre Dumas, The Three Musketeers We have kicked off the second half of 2019 with the S&P 500 at all-time highs after rallying some 17% so far this year. That is the best first half of performance for the index since 1997. One...

SOUTH SAN FRANCISCO, Calif., July 02, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...

Calithera Biosciences (NASDAQ: CALA ) is up 4.5% after hours following a filing disclosing a purchase of just over $200,000 worth of stock by the CEO's family trust. More news on: Calithera Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., June 21, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...

Gainers:  Melinta Therapeutics (NASDAQ: MLNT ) +180% . Arcturus Therapeutics (NASDAQ: ARCT ) +37% . Hebron Technology (NASDAQ: HEBT ) +26% . MYOS RENS Technology (NASDAQ: MYOS ) +22% . Armata Pharmaceuticals (NYSEMKT: ARMP ) +19% . AquaBounty Technologies (NASDAQ: AQB ) +19% . D...

Sesen Bio (NASDAQ: SESN )  -32%  on pricing equity offering. More news on: Sesen Bio, Inc., Tonix Pharmaceuticals Holding Corp., Calithera Biosciences, Inc., Stocks on the move, Read more ...

Calithera Biosciences (NASDAQ: CALA ) has priced its public offering of 12.5M common shares at $4/share, for gross proceeds of $50M. More news on: Calithera Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced...

Gainers:  MoneyGram International (NASDAQ: MGI ) +106% . China Internet Nationwide Financial Services (NASDAQ: CIFS ) +33% . G1 Therapeutics (NASDAQ: GTHX ) +26% . SunPower Corporation (NASDAQ: SPWR ) +24% . Sundance Energy Australia (NASDAQ: SNDE ) +20% . Cortexyme (NASDAQ: CRTX...

Digital Ally (NASDAQ: DGLY )  -42%  on Axon patent win. More news on: Digital Ally, Inc., ContraVir Pharmaceuticals, Inc., Biohaven Pharmaceutical Holding Company Ltd., Stocks on the move, Read more ...